MRLTX | VIGIX | MRLTX / VIGIX | |
Total Expense Ratio | 1.00 | 0.04 | 2,500% |
Annual Report Gross Expense Ratio | 1.11 | 0.04 | 2,775% |
Fund Existence | 16 years | 27 years | - |
Gain YTD | 6.383 | 9.615 | 66% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 138M | 312B | 0% |
Annual Yield % from dividends | 0.00 | 0.45 | - |
Returns for 1 year | 4.00 | 21.22 | 19% |
Returns for 3 years | 26.57 | 87.63 | 30% |
Returns for 5 years | 36.03 | 108.41 | 33% |
Returns for 10 years | 66.96 | 313.80 | 21% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MIDLX | 34.45 | 0.19 | +0.55% |
MFS International New Discovery R6 | |||
RMATX | 11.42 | 0.04 | +0.35% |
Russell Inv Multi-Asset Strat M | |||
RYMSX | 24.54 | 0.03 | +0.12% |
Guggenheim Multi-Hedge Strategies P | |||
DPLGX | 28.23 | -0.03 | -0.11% |
Jackson Square Large-Cap Growth IS | |||
LGOAX | 41.95 | -0.05 | -0.12% |
Patient Opportunity A |